Bart Westendorp
Impact in
- Cancer Research top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 7
- Ubiquitin and proteasome pathways 7
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 5
- Oncology 16
- Cancer-related Molecular Pathways 11
- Co-authors
- Alain de Bruin (21 shared papers)Shusil K. Pandit (3 shared papers)Peter C.J. Tooten (3 shared papers)Michal Mokrý (2 shared papers)M.J.M. Toussaint (4 shared papers)Marian J.A. Groot Koerkamp (1 shared paper)Edwin Cuppen (1 shared paper)Frank C. P. Holstege (1 shared paper)
- Journals
- Oncogene (4 papers)The EMBO Journal (3 papers)European Journal of Pharmacology (2 papers)Molecular Cancer Research (2 papers)EMBO Reports (2 papers)
- Partner nations
- NetherlandsUnited StatesPakistan
In The Last Decade
Bart Westendorp
37 papers receiving 865 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 167
- Oncology 270
- Cell Biology 152
- Molecular Biology 604
- Hepatology 62
Countries citing papers authored by Bart Westendorp
This map shows the geographic impact of Bart Westendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Westendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Westendorp more than expected).
Fields of papers citing papers by Bart Westendorp
This network shows the impact of papers produced by Bart Westendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Westendorp. The network helps show where Bart Westendorp may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Westendorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 124 | |
| 2 | 2013 | 121 | |
| 3 | 2012 | 103 | |
| 4 | 2011 | 96 | |
| 5 | 2016 | 52 | |
| 6 | 2019 | 35 | |
| 7 | 2020 | 28 | |
| 8 | 2016 | 26 | |
| 9 | 2018 | 25 | |
| 10 | 2011 | 25 | |
| 11 | 2020 | 20 | |
| 12 | 2020 | 20 | |
| 13 | 2023 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2013 | 17 | |
| 16 | 2012 | 17 | |
| 17 | 2021 | 14 | |
| 18 | 2022 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2022 | 10 |
About Bart Westendorp
Bart Westendorp is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Cancer Research and Cell Biology, having authored 41 papers that have together received 869 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), DNA Repair Mechanisms (7 papers), Ubiquitin and proteasome pathways (7 papers), Renin-Angiotensin System Studies (6 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (5 papers), Microtubule and mitosis dynamics (4 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Cancer Research (167 citations), Oncology (270 citations), Cell Biology (152 citations), Molecular Biology (604 citations) and Hepatology (62 citations). Bart Westendorp has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include Alain de Bruin, Shusil K. Pandit, Peter C.J. Tooten, Michal Mokrý, M.J.M. Toussaint, Marian J.A. Groot Koerkamp, Edwin Cuppen, Frank C. P. Holstege, Wouter H. Lamers and Walbert J. Bakker. Their work appears in journals such as Oncogene, The EMBO Journal, European Journal of Pharmacology, Molecular Cancer Research and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.